Sign inJoin waitlistJoin the waitlist

Laurie B. Grossberg

Director, Inflammatory Bowel Disease Clinical Trials Program · Beth Israel Deaconess Medical Center

Credentials: · ·

History

Inflammatory Bowel Disease Clinical Trials Program · Beth Israel Deaconess Medical Center
Present
Harvard Medical School
Present

BIDMC
BIDMC
George Washington University School of Medicine
2011

Research

The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
Blood · 2011 · 236 citations
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
Blood · 2008 · 167 citations
The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome
Alimentary Pharmacology & Therapeutics · 2013 · 93 citations

Adam Cheifetz
24 papers
Loren Rabinowitz
12 papers
Joseph Feuerstein
9 papers
Tina Deyhim
9 papers
Samantha Zullow
8 papers
Ajay Gade
6 papers
Alessandra Saraga
6 papers · 6 as a fellow
Daniel Leffler
6 papers
Mandeep Sawhney
3 papers
Rachel Porth
3 papers
SB
Sarah Ballou
3 papers
Shana Rakowsky
3 papers · 2 as a fellow

Clinical trials

Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis
Principal investigator · Withdrawn
Beth Israel Deaconess Medical Center
2023–2024